Apellis Pharmaceuticals Inc (NASDAQ: APLS) open the trading on Wednesday, with a bit cautious approach as it glided -5.17% to $27.49, before settling in for
A new trading day began on Friday, with Apellis Pharmaceuticals Inc (NASDAQ: APLS) stock price down -6.38% from the previous day of trading, before settling
Witnessing the stock’s movement on the chart, on Wednesday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) had a quiet start as it plunged -3.45% to $28.25, before
On Friday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) was 4.31% up from the session before settling in for the closing price of $28.74. A 52-week range
On Monday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) was 2.07% up from the session before settling in for the closing price of $27.98. A 52-week range
Apellis Pharmaceuticals Inc (NASDAQ: APLS) flaunted slowness of -1.62% at $27.26, before settling in for the price of $27.71 at the close. Taking a more
Apellis Pharmaceuticals Inc (NASDAQ: APLS) kicked off on Monday, up 2.47% from the previous trading day, before settling in for the closing price of $26.68.
As on Thursday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) got off with the flyer as it spiked 2.22% to $27.58, before settling in for the price
Apellis Pharmaceuticals Inc (NASDAQ: APLS) on Monday, plunged -4.00% from the previous trading day, before settling in for the closing price of $28.00. Within the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
